Concord Biotech Limited (CONCORDBIO) — Announcement | 20 June 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Concord Biotech announced it will invest ₹6.3 crores to acquire 27.38% equity in FSGE Renewable Power Private Limited, a newly incorporated Gujarat-based special purpose vehicle developing a 6.3 MW wind-solar hybrid project for its Limbasi facility. The transaction, structured as a cash consideration at arm's length, aligns with the company's sustainability goals and aims to reduce long-term energy costs through renewable power generation. The investment will be completed within 60 days of the agreement date.

📄 View Original Announcement (PDF)

About Concord Biotech Limited (CONCORDBIO)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹15,212.77 Cr P/E: 55.7 ROE: 13.5% ROCE: 18.1% Div Yield: 0.52%

View full CONCORDBIO stock details →

📡 Get AI alerts when CONCORDBIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CONCORDBIO — Free

📊 More CONCORDBIO filings

See all CONCORDBIO filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CONCORDBIO files new disclosures

Track CONCORDBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CONCORDBIO — Free

Free account · 2 AI queries/day